Cargando…
The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure
OBJECTIVE: Dysregulation of the complement system has been described in patients with heart failure (HF). However, data on the alternative pathway are scarce and it is unknown if levels of factor B (FB) and the C3 convertase C3bBbP are elevated in these patients. We hypothesized that plasma levels o...
Autores principales: | Holt, Margrethe Flesvig, Michelsen, Annika E., Shahini, Negar, Bjørkelund, Elisabeth, Bendz, Christina Holt, Massey, Richard J., Schjalm, Camilla, Halvorsen, Bente, Broch, Kaspar, Ueland, Thor, Gullestad, Lars, Nilsson, Per H., Aukrust, Pål, Mollnes, Tom Eirik, Louwe, Mieke C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738166/ https://www.ncbi.nlm.nih.gov/pubmed/35003128 http://dx.doi.org/10.3389/fimmu.2021.800978 |
Ejemplares similares
-
The alternative complement pathway is dysregulated in patients with chronic heart failure
por: Shahini, Negar, et al.
Publicado: (2017) -
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021) -
Targeting the Inflammasome in Cardiovascular Disease
por: Olsen, Maria Belland, et al.
Publicado: (2021) -
Distinct patterns of soluble leukocyte activation markers are associated with etiology and outcomes in precapillary pulmonary hypertension
por: Lekva, Tove, et al.
Publicado: (2020) -
Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipients
por: Yardley, Marianne, et al.
Publicado: (2017)